De novo-designed transmembrane domains tune engineered receptor functions
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
De novo-designed receptor transmembrane domains (TMDs) present opportunities for precise control of cellular receptor functions. We developed a de novo design strategy for generating programmed membrane proteins (proMPs): single-pass α-helical TMDs that self-assemble through computationally defined and crystallographically validated interfaces. We used these proMPs to program specific oligomeric interactions into a chimeric antigen receptor (CAR) that we expressed in mouse primary T cells and found that both in vitro CAR T cell cytokine release and in vivo antitumor activity scaled linearly with the oligomeric state encoded by the receptor TMD, from monomers up to tetramers. All programmed CARs stimulated substantially lower T cell cytokine release relative to the commonly used CD28 TMD, which we show elevated cytokine release through lateral recruitment of the endogenous T cell costimulatory receptor CD28. Precise design using orthogonal and modular TMDs thus provides a new way to program receptor structure and predictably tune activity for basic or applied synthetic biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207 · cited 1×
“The importance of high precision in receptor engineering has come into particularly sharp focus with the clinical adoption of cancer immunotherapies using targeted chimeric antigen receptors (CARs) (Eshhar et al., 1993; June et al., 2018; Majzner and Mackall, 2019; Salter et al., 2018) to endow T cells with potent ant…”
BackgroundCalibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Feucht, J., Sun, J., Eyquem, J., Ho, Y.-J., Zhao, Z., Leibold, J., Dobrin, A., Cabriolu, A., Hamieh, M., & Sadelain, M. (2019) · Nature Medicine · doi:10.1038/s41591-018-0290-5 · Cited by 547
Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor
Fu, Q., Fu, T.-M., Cruz, A. C., Sengupta, P., Thomas, S. K., Wang, S., Siegel, R. M., Wu, H., & Chou, J. J. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.009 · Cited by 191 · cited 1×
“, 2019), death receptors (Fu et al., 2016; Pan et al., 2019) and growth factor receptors (Arkhipov et al.”
Background
Cited by
De novo protein design—From new structures to programmable functions
Kortemme, T. (2024) · Cell · doi:10.1016/j.cell.2023.12.028 · Cited by 344
Yan, J., Wang, S.-Y., Su, Q., Zou, M.-W., Zhou, Z.-Y., Shou, J., & Huo, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-59093-7 · Cited by 62
“In addition to the traditionalCARdesignwithaCD28 transmembranedomain(TMD),we introduced a de novo TMD design following a programmable membrane protein (proMP) strategy 16 .”
InfluentialAssessing and enhancing foldability in designed proteins
Listov, D., Lipsh‐Sokolik, R., Rosset, S., Yang, C., Correia, B. E., & Fleishman, S. J. (2022) · Protein Science · doi:10.1002/pro.4400 · Cited by 24
Self-citationImproving diffusion-based protein backbone generation with global-geometry-aware latent encoding
(2025) · doi:10.1038/s42256-025-01059-x · Cited by 7
Corcoran, W. K., Cosio, A., Edelstein, H. I., & Leonard, J. N. (2025) · GEN Biotechnology · doi:10.1089/genbio.2024.0057 · Cited by 4
Metadata
- Authors
- Elazar, A., Chandler, N. J., Davey, A. S., Weinstein, J. Y., Nguyen, J. V., Trenker, R., Cross, R. S., Jenkins, M. R., Call, M. J., Call, M. E., & Fleishman, S. J.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2022-05-04
- Volume
- 11
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W4229043548
- Cited by
- 58
- References
- 3
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: De novo-designed transmembrane domains tune engineered receptor functions. https://app.cochat.ai/papers/10.7554/elife.75660
- The paper
- Elazar, A., Chandler, N. J., Davey, A. S., Weinstein, J. Y., Nguyen, J. V., Trenker, R., Cross, R. S., Jenkins, M. R., Call, M. J., Call, M. E., & Fleishman, S. J. (2022). De novo-designed transmembrane domains tune engineered receptor functions. eLife. https://doi.org/10.7554/elife.75660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.